| View |
|
HRP-417-06
|
Tretinoin + Hydroquinone
|
None
|
10 mg/2 g per 100 mL (0.01%/2%)
|
Topical Solution
|
Exfoliant / Anti-Acne / Depigmenting
|
Refinette Cosmetic Manufacturing Corporation
|
Philippines
|
CLIDP Conversion
|
12 October 2023
|
15 March 2026
|
| View |
|
BR-1450
|
Heparin Sodium
|
Unihepa
|
5,000 I.U./mL (25,000 I.U./5mL)
|
Solution for Injection (IV/SC)
|
Anticoagulant
|
Duopharma (M) Sdn. Bhd.
|
Malaysia
|
Renewal
|
23 October 2023
|
03 February 2029
|
| View |
|
BRP-044-01
|
Human Albumin
|
Humin
|
200 g/L (20% w/v)
|
Solution for IV Infusion
|
Plasma Fraction for Specific Use
|
Virchow Biotech Pvt. Ltd.
|
India
|
CLIDP Conversion
|
19 October 2023
|
09 February 2026
|
| View |
|
DRP-10035-01
|
Salbutamol (As Sulfate)
|
Retavent
|
2mg/5mL
|
Oral Solution
|
Selective Beta-2-Adrenoreceptor Agonist
|
Rhydburg Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
18 October 2023
|
03 September 2026
|
| View |
|
DRP-10137-02
|
Losartan Potassium + Hydrochlorothiazide
|
Retazar Plus
|
50mg/12.5mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker/Diuretic
|
ACME Formulation Pvt. Ltd
|
India
|
CLIDP Conversion
|
19 October 2023
|
29 July 2026
|
| View |
|
DRP-10299-03
|
Paracetamol + Phenylephrine Hydrochloride + Chlorphenamine Maleate
|
Hyzef
|
500mg/ 10mg/ 2mg
|
Capsule
|
Nasal Decongestant/Antihistamine/Analgesic/Antipyretic
|
LifeSquare Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
18 October 2023
|
07 September 2026
|
| View |
|
DRP-1034-03
|
Ciprofloxacin (as hydrochloride)
|
Ciproted
|
500 mg
|
Film-Coated Tablet
|
Antibacterial [Quinolone (Flourinated)]
|
Umedica Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
23 October 2023
|
27 August 2028
|
| View |
|
DRP-10440-02
|
Ceftriaxone (as sodium)
|
Xokem
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
NCPC Hebei Huamin Pharmaceutical Company Limited
|
China
|
CLIDP Conversion
|
23 October 2023
|
08 October 2026
|
| View |
|
DRP-10620-02
|
Azithromycin (As Dihydrate)
|
Azithrocass
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Macrolide)
|
Zim Laboratories Limited
|
India
|
CLIDP Conversion
|
19 October 2023
|
10 November 2026
|
| View |
|
DRP-10810-01
|
Omeprazole
|
Retaprez
|
20mg
|
Delayed-Release Capsule
|
Proton Pump Inhibitor
|
ACME Formulation Pvt. Ltd
|
India
|
CLIDP Conversion
|
19 October 2023
|
26 November 2026
|
| View |
|
DRP-10907-01
|
Levetiracetam
|
Levixam
|
500 mg
|
Tablet
|
Antiepileptic
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
20 October 2023
|
23 December 2026
|
| View |
|
DRP-11057-05
|
Clopidogrel
|
None
|
75 mg
|
Film Coated Tablet
|
Platelet Aggregation Inhibitor
|
Centurion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
23 October 2023
|
20 January 2027
|
| View |
|
DRP-11177-02
|
Salbutamol (as sulfate)
|
Retavent
|
1 mg/mL (2.5mg/2.5mL)
|
Solution for Inhalation
|
Anti-Asthma (Selective Beta-2-Adrenoreceptor Agonist)
|
Legency Remedies Pvt. Ltd
|
India
|
CLIDP Conversion
|
18 October 2023
|
16 February 2027
|
| View |
|
DRP-11179-01
|
Levetiracetam
|
Levixam
|
100 mg/mL (500 mg/5 mL)
|
Solution for Injection (IV)
|
Antiepileptic
|
Hainan Poly Pharm. Co., Ltd
|
China
|
CLIDP Conversion
|
19 October 2023
|
10 February 2027
|
| View |
|
DRP-11299-01
|
Rocuronium Bromide
|
RocuGet
|
10 mg/mL
|
Solution for Injection (IV)
|
Muscle Relaxant
|
Aspiro Pharma Limited
|
N/A
|
CLIDP Conversion
|
18 October 2023
|
24 November 2026
|
| View |
|
DRP-11882-01
|
Salbutamol (as sulfate)+ Ipratropium (as bromide)
|
Retavent Plus
|
2.5 mg / 500 mcg per 2.5 mL
|
Solution for Inhalation
|
Adrenergics in combination with anticholinergic
|
Ahlcon Parenterals (India) Limited
|
India
|
CLIDP Conversion
|
18 October 2023
|
16 May 2027
|
| View |
|
DRP-11927-04
|
Meropenem
|
Carbacent
|
1 g
|
Powder for Injection (IV)
|
Antibacterial (Carbapenem)
|
Uni Medicolabs
|
India
|
CLIDP Conversion
|
18 October 2023
|
20 May 2027
|
| View |
|
DRP-12292-02
|
Febuxostat
|
Rifexostat
|
40 mg
|
Film-Coated Tablet
|
Antigout
|
Cooper Pharma Limited
|
India
|
CLIDP Conversion
|
16 October 2023
|
12 July 2027
|
| View |
|
DRP-12540-02
|
Meropenem (as trihydrate)
|
Emero 500
|
500 mg
|
Powder for Injection (IV)
|
Antibacterial (Carbapenem)
|
Brooks Steriscience Limited
|
India
|
CLIDP Conversion
|
23 October 2023
|
30 August 2027
|
| View |
|
DRP-12561-07
|
Metformin hydrochloride
|
Switles
|
500 mg
|
Film-Coated Tablet
|
Oral hypoglycemic Agent (Biguanide)
|
Azarias Pharmaceutical Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
19 October 2023
|
02 September 2027
|